High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection

Strahlentherapie und Onkologie

Volumn 178, Issue 8, 2002, Pages 426-435

  Rödel, Franz ^a   Hoffmann, Jörg ^a   Grabenbauer, Gerhard G ^a   Papadopoulos, Thomas ^a   Weiß, Christian ^a   Günther, Klaus ^a   Schick, Christoph ^a   Sauer, Rolf ^a   Rödel, Claus ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Neoadjuvant radiochemotherapy; Rectal cancer; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2; PROTEIN P53; SURVIVIN;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; RECTUM BIOPSY; RECTUM CARCINOMA; SURGICAL TECHNIQUE; TREATMENT FAILURE;

ADENOCARCINOMA; ADULT; APOPTOSIS; BIOPSY; CHEMOTHERAPY, ADJUVANT; CHROMOSOMAL PROTEINS, NON-HISTONE; COMBINED MODALITY THERAPY; CYSTEINE PROTEINASE INHIBITORS; DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; FEMALE; GENES, BCL-2; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; TIME FACTORS;

EID: 0036338868     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-1003-y     Document Type: Article

References (51)

1. Apoptosis and p53 overexpression in human rectal cancer; relationship with response to hyperthermo-chemo-radiotherapy
2. Apoptosis in rectal carcinoma. Prognosis and recurrence after preoperative radiotherapy
3. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
4. The postoperative adjuvant radiotherapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis
5. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas - Aspects of carcinogenesis and prognostic significance
6. Radiation-induced apoptosis in human colorectal adenoma and carcinoma cell lines can occur in the absence of wild type p53
7. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis
8. p53: Biology and role for cellular radiosensitivity
9. X-linked IAP is a direct inhibitor of cell-death proteases
10. Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?
11. Metaanalyse zur präoperativen radiotherapie beim resektablen rektumkarzinom: Verbesserung der gesamtüberlebensrate, tumorspezifischen überlebensrate und der lokalrezidivrate durch die präoperative bestrahlung
12. Influence of the interval between preoperative radiation therapy and surgery on downstaging and the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial
13. DNA demethylase is expressed in ovarian cancers and the expression correlates with demetylation of CpG sites in the promoter region of c-erb-2 and survivin genes
14. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
15. Adjuvante therapie bei kolon- und rektumkarzinom
16. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
17. Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients
18. Expression of survivin in esophageal cancer: Correlation with prognosis and response to chemotherapy
19. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
20. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis
21. First results of neoadjuvant simultaneous radiochemotherapy in advanced rectal carcinoma
22. The inhibitor of apoptosis (IAPs) and their emerging role in cancer
23. Short-term hypofractionated radiotherapy followed by mesorectal excision
24. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
25. Cell cycle arrest and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity
26. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting
27. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies
28. Programmed cell death and radioresistance
29. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy
30. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognostic marker in non-small-cell lung cancer
31. Influence of p53 status on prognosis in preoperatively irradiated rectal carcinoma
32. Adjuvant therapy for patients with colon and rectal cancer
33. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
34. A novel antisens oligonucleotide targeting surviving expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
35. Molecular prognostic factors in rectal cancer treated by radiation and surgery
36. Relationship between radiation response and p53 status in human bladder cancer cells
37. Downstaging of T3 rectal cancer after preoperative infusional chemoradiation is correlated with spontaneous apoptosis index and bcl-2 staining
38. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer
39. Apoptosis, p53, Ki-67 and bcl-2: Possible predictors for successful bladder preservation by transurethral resection and radiochemotherapy
40. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer
41. The importance of the interval between preoperative radiotherapy and the operation in the treatment of rectal carcinoma
42. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal cancer
43. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumor
44. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94)
45. A histopathological assessment of response of rectal adenocarcinoma to combination chemo-radiotherapy: Relationship to apoptotic activity, p53 and bcl-2 expression
46. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
47. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas
48. Apoptosis, proliferation, Bax, Bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer
49. Präoperative radiotherapie vor totaler mesorek-taler exzision (TME) bei rektumkarzinomen
50. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: Long tern follow-up
51. Activation of the K-ras oncogene in colorectal neoplasm is associated with decreased apoptosis